NASDAQ:KRBP Shareholder Notice: Lawsuit Alleges Securities Laws Violations by Kiromic BioPharma, Inc.
An investor, who purchased NASDAQ:KRBP shares, filed a lawsuit against Kiromic BioPharma, Inc over alleged violations of Federal Securities Laws by Kiromic BioPharma, Inc. in connection with certain allegedly false and misleading statements made between June 25, 2021 and August 13, 2021 and in connection with The Company's public offering closed on July 2, 2021 (the Offering).
View full press release